GPR128 | G protein-coupled receptor 128 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GPR35 | G protein-coupled receptor 35 | G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
GSDMB | Gasdermin B | Predicted intracellular proteins
| | | | | Tissue enhanced |
HKDC1 | Hexokinase domain containing 1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
HRASLS2 | HRAS-like suppressor 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
HSD17B2 | Hydroxysteroid (17-beta) dehydrogenase 2 | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
HTR1D | 5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
HTR3E | 5-hydroxytryptamine (serotonin) receptor 3E, ionotropic | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
HTR4 | 5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled | FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ITPKA | Inositol-trisphosphate 3-kinase A | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
KCNK10 | Potassium channel, subfamily K, member 10 | Predicted membrane proteins
| | | | | Tissue enhanced |
KRT20 | Keratin 20 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
LBX2 | Ladybird homeobox 2 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
LCN15 | Lipocalin 15 | Predicted secreted proteins
| | | | | Tissue enhanced |
LMX1A | LIM homeobox transcription factor 1, alpha | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
LRRC66 | Leucine rich repeat containing 66 | Predicted membrane proteins
| | | | | Tissue enhanced |
LRRC75A | Leucine rich repeat containing 75A | Predicted intracellular proteins
| | | | | Tissue enhanced |
MIA2 | Melanoma inhibitory activity 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
MISP | Mitotic spindle positioning | Cytoskeleton related proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
MME | Membrane metallo-endopeptidase | Cancer-related genes Candidate cardiovascular disease genes CD markers Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
MNX1 | Motor neuron and pancreas homeobox 1 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
MT1B | Metallothionein 1B | Predicted intracellular proteins
| | | | | Tissue enhanced |
MUC3A | Mucin 3A, cell surface associated | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MYO7B | Myosin VIIB | Cytoskeleton related proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
NAGS | N-acetylglutamate synthase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
NEUROG3 | Neurogenin 3 | Disease related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
NR0B2 | Nuclear receptor subfamily 0, group B, member 2 | Disease related genes Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
NR1I2 | Nuclear receptor subfamily 1, group I, member 2 | FDA approved drug targets Nuclear receptors Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
OLFM4 | Olfactomedin 4 | Predicted secreted proteins
| | | | | Tissue enhanced |
OMP | Olfactory marker protein | Predicted intracellular proteins
| | | | | Tissue enhanced |
ONECUT2 | One cut homeobox 2 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
PAX4 | Paired box 4 | Disease related genes Predicted intracellular proteins Predicted secreted proteins Transcription factors
| | | | | Tissue enhanced |
PDZD3 | PDZ domain containing 3 | Predicted intracellular proteins
| | | | | Tissue enhanced |
PDZD7 | PDZ domain containing 7 | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
PIGR | Polymeric immunoglobulin receptor | Cancer-related genes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
PLEKHS1 | Pleckstrin homology domain containing, family S member 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
PLS1 | Plastin 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
PPP1R14D | Protein phosphatase 1, regulatory (inhibitor) subunit 14D | Predicted intracellular proteins
| | | | | Tissue enhanced |
PRAP1 | Proline-rich acidic protein 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
PRDM16 | PR domain containing 16 | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
PRR15 | Proline rich 15 | Predicted intracellular proteins
| | | | | Tissue enhanced |
PRR15L | Proline rich 15-like | Predicted intracellular proteins
| | | | | Tissue enhanced |
PTPRH | Protein tyrosine phosphatase, receptor type, H | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
REEP6 | Receptor accessory protein 6 | Predicted membrane proteins
| | | | | Tissue enhanced |
REG1B | Regenerating islet-derived 1 beta | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
RNF186 | Ring finger protein 186 | Predicted membrane proteins
| | | | | Tissue enhanced |
RP11-1220K2.2 | Homo sapiens maltase-glucoamylase (alpha-glucosidase) (LOC93432), mRNA. | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
RP11-407N17.3 | CTAGE family member 5 {ECO:0000313|Ensembl:ENSP00000452252} | Predicted membrane proteins
| | | | | Tissue enhanced |
RXFP4 | Relaxin/insulin-like family peptide receptor 4 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
SDCBP2 | Syndecan binding protein (syntenin) 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |